Amicus Therapeutics
IPOHome - Amicus Therapeutics | Advancing Therapies to Treat Rare Diseases
Public · Cranbury, United States · Founded 2002 · $86.0M raised
- Headquarters
- Cranbury, New Jersey
- Employees
- 501–1000
- Founded
- 2002
- Business Model
- B2B
- Website
- amicusrx.com
- Total Funding
- $86.0M
- Last Round
- $55.0M Venture RoundJan 2006
- Rounds
- 4
- Type
- Public
About
Oral pharmacological chaperone protein therapies to address diseases that result from protein misfolding
Summary
Amicus Therapeutics is a Biotech company based in Cranbury, United States, founded in 2002. It has raised $86.0M in total across 4 rounds, most recently a $55.0M Venture Round round in Jan 2006.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2025
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...